Revvity launches SuperFlex prenatal screening system for preeclampsia testing
Revvity, Inc. has launched the SuperFlex™ prenatal screening system, a compact, CE-IVDR certified immunoassay instrument designed for laboratories and clinics operating lower-volume workflows. The Waltham, Massachusetts-based company said the platform is intended to bring reliable, rapid screening capability to facilities that have historically lacked access to centralised, high-throughput testing.











